| Literature DB >> 31049441 |
Aliya Nur Hasanah1, Driyanti Rahayu1, Rimadani Pratiwi1, Tina Rostinawati1, Sandra Megantara1, Febrina Amelia Saputri1, Khanifa Hidayati Puspanegara1.
Abstract
Atenolol (ATE) is a cardio-selective β-blocker that is used in the treatment of hypertension over extended periods. However, ATE, like propranolol, has major potential for misuse as a performance-enhancing drug in several sports. Therefore, an efficient and selective separation method is required to detect and monitor the level of ATE in the body. This paper presents a molecularly imprinted polymer with specific and selective binding to ATE using precipitation polymerization. We show that when employed in an optimized molecular imprinted solid phase extraction (MI-SPE) protocol, recoveries of 93.65 ± 1.29% from spiked blood serum with excellent discrimination from other β-blocker drugs is possible. The methodology used in this study includes molecular modeling interaction between ATE and itaconic acid (ITA) as functional monomer, followed by determination of binding constants with spectrophotometry, synthesis of the polymer using precipitation polymerization and ending with characterization and application of polymers to extract ATE in serum. Docking analysis revealed a binding affinity between ATE and ITA of -2.0 kcal/mol with the formation of hydrogen bonding. The association constant between ATE and ITA was studied by UV titration in two different solvents, with evidence of an association constant 6.277 × 102 M-1 measured in acetonitrile: methanol (1:1). An optimized MI-SPE protocol was developed for the extraction of ATE from spiked blood serum, obtaining recoveries of 93.65% with excellent selectivity toward other β-blocker drugs.Entities:
Keywords: Analytical chemistry; Materials chemistry; Pharmaceutical chemistry
Year: 2019 PMID: 31049441 PMCID: PMC6479165 DOI: 10.1016/j.heliyon.2019.e01533
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
The composition of MIP and NIP Atenolol.
| Polymer | Functional monomer (1 mmol) | Porogen (350 mL) | Crosslinker (20 mmol) | Template (1 mmol) | Method |
|---|---|---|---|---|---|
| MIP 1 | Itaconic acid | Methanol: Acetonitrile | EGDMA | Atenolol | Precipitation polymerization |
| NIP 1 | Itaconic acid | Methanol: Acetonitrile | EGDMA | - | Precipitation polymerization |
| MIP 2 | Itaconic acid | Methanol | EGDMA | Atenolol | Precipitation polymerization |
| NIP 2 | Itaconic acid | Methanol | EGDMA | - | Precipitation polymerization |
Fig. 1Result of analysis of the interactions in the prepolymerization complex (a) ITA-ATE (b) MAA-ATE.
Association constant results of ITA – atenolol on different solvent.
| Monomer | Solvent | Template | Ka (M−1) |
|---|---|---|---|
| Itaconic acid | Methanol: acetonitrile | Atenolol | 6.277 × 102 |
| Itaconic acid | Methanol | Atenolol | 5.43 × 102 |
Fig. 2Schematic diagram of MI-SPE ATE synthesis.
Adsorption isotherm linear regresion Freundlich model result.
| Polymer | m | a (mg/g) |
|---|---|---|
| MIP 1 | 3.039 | 4.250 |
| NIP 1 | 0.209 | 0.164 |
| MIP 2 | 0.603 | 0.269 |
| NIP 2 | 0.881 | 0.062 |
Fig. 3Recoveries and imprinting factor value of blood serum spiked with ATE alone and mix of ATE with other β blockers.
Fig. 4Chromatogram of (a) blank sample serum, (b) spiked sample serum without MIP 1 pre-treatment, (c) spiked sample serum with MIP 1 pre-treatment.
Fig. 5FTIR spectra of MIP 1 (a) and NIP 1 (b).
Fig. 6SEM of MIP 1 (a) and NIP 1 (b).